CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

CVS adds weight-loss drug, Zepbound, back to preferred coverage

In a reversal from last year, CVS will begin covering Eli Lilly's Zepbound and Foundayo in its standard prescription plan, a ...

CVS Caremark will cover Lilly's weight loss drug Zepbound again after patient backlash

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered ...
FOX 5 Atlanta

CVS Caremark to cover Zepbound again after lawsuit, widespread backlash

CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a ...

CVS will add these weight-loss options to drug plans

CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill ...

CVS brings back coverage for Lilly's obesity drug Zepbound

By Sriparna Roy May 28 (Reuters) - CVS Health will restore Eli Lilly's weight-loss injection Zepbound to its list of covered ...

CVS Health reintroduces coverage for Lilly’s Zepbound

Eli Lilly (LLY) stock is in focus as CVS Health (CVS) restores Zepbound coverage effective Oct 1, 2026, and adds Foundayo to ...
Honolulu Star-Advertiser

CVS restores Eli Lilly Zepbound weight loss drug coverage

CVS Health will restore Eli Lilly’s weight-loss injection Zepbound to its list of covered drugs and also add the drugmaker’s ...
Hoodline

CVS Reinstates Zepbound Coverage On Some Formularies

CVS Caremark is putting Eli Lilly’s obesity drug Zepbound back on some commercial formularies starting Oct. 1, reversing a mid-2025 decision that had nudged many patients toward rival GLP-1 ...